Pharmaco - Press Releases

Date	Title	Company
27-Dec-2022	Marinomed Biotech AG: Marinomed Biotech receives US Patent approval for the Marinosolv® technology and invests in a series of new patents	Marinomed Biotech AG
27-Dec-2022	Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission	Relief Therapeutics Holding SA
27-Dec-2022	Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders	Relief Therapeutics Holding SA
23-Dec-2022	Pareto Securities AS publishes buy recommendation for Epigenomics AG share	Epigenomics AG
22-Dec-2022	10-year Moderna deal underlines UK potential for global life science leadership	Moderna
22-Dec-2022	MODERNA FINALIZES STRATEGIC PARTNERSHIP WITH UK GOVERNMENT	MODERNA
21-Dec-2022	Asklepios Kliniken: Asklepios signs off on first-ever commercial paper program for EUR 500 million	Asklepios Kliniken
21-Dec-2022	Epigenomics AG: Further raise of earnings guidance for the current fiscal year 2022	Epigenomics AG
21-Dec-2022	Cosmo and Hyphens Announce Signing of License and Supply Agreements for Winlevi® in Southeast Asia	Cosmo Pharmaceuticals N.V.
20-Dec-2022	Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023	MorphoSys AG
20-Dec-2022	Change in the Supervisory Board of Eckert & Ziegler AG	Eckert & Ziegler Strahlen- und Medizintechnik AG
20-Dec-2022	Abivax receives FDA agreement on pediatric development plan with obefazimod in IBD	ABIVAX
20-Dec-2022	BREAKTHROUGH RESULTS: DEFENCE’S NOVEL ACCUTOXTM INTRANASAL REDUCED 50% OF CANCER NODULES ON ANIMALS WITH LUNG TUMORS	Defence Therapeutics Inc.
20-Dec-2022	2cureX reaches 2022 geographic rollout goal of 20 countries	2cureX
20-Dec-2022	Defence Therapeutics Inc.: BREAKTHROUGH RESULTS: DEFENCE’S NOVEL ACCUTOXTM INTRANASAL REDUCED 50% OF CANCER NODULES ON ANIMALS WITH LUNG TUMORS	Defence Therapeutics Inc.
20-Dec-2022	Douglas GmbH: Resilient business model: DOUGLAS with further sales and earnings growth	Douglas GmbH
20-Dec-2022	Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements	Relief Therapeutics Holding SA
20-Dec-2022	Novotech is Gold Sponsor at Biotech Showcase 2023	Novotech Health Holdings Pte Ltd
19-Dec-2022	Changes in the Management Board of Eckert & Ziegler	Eckert & Ziegler Strahlen- und Medizintechnik AG
19-Dec-2022	Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership	B3C newswire